E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT.
Open accessThe DOI matches its Crossref record; 65 of the 67 references it cites were found in a registry or an index.
Abstract
Background: Over the past few years, a large number of smokers in the UK have stopped smoking with the help of e-cigarettes. So far, UK Stop Smoking Services (SSSs) have been reluctant to include e-cigarettes among their treatment options because data on their efficacy compared with the licensed medications are lacking. Objective: The objective was to compare the efficacy of refillable e-cigarettes and nicotine replacement therapy (NRT) products, when accompanied by weekly behavioural support. Design: A randomised controlled trial comparing e-cigarettes and NRT. Setting: Three sites that provide local SSSs. Participants: The participants were 886 smokers seeking help to quit smoking, aged ≥ 18 years, not pregnant or breastfeeding, with no strong preference to use or not to use NRT or e-cigarettes in their quit attempt, and currently not using NRT or e-cigarettes. A total of 886 participants were randomised but two died during the study (one in each study arm) and were not included in the analysis. Interventions: The NRT arm ( n = 446) received NRT of their choice (single or combination), provided for up to 12 weeks. The e-cigarette arm ( n = 438) received an e-cigarette starter pack and were encouraged to buy addtional e-liquids and e-cigarette products of their choice. Both arms received the same standard behavioural support. Participants attended weekly sessions at their SSS and provided outcome data at 4 weeks. They were then followed up by telephone at 6 and 12 months. Participants reporting abstinence or at least 50% reduction in cigarette consumption at 12 months were invited to attend for carbon monoxide (CO) validation. Participants/researchers could not be blinded to the intervention. Main outcome measures: The primary outcome was CO-validated sustained abstinence rates at 52 weeks. Participants lost to follow-up or not providing biochemical validation were included as non-abstainers. Secondary outcomes included abstinence at other time points, reduction in smoke intake, treatment adherence and ratings, elicited adverse reactions, and changes in self-reported respiratory health. A cost-efficacy analysis of the intervention was also conducted. Results: The 1-year quit rate was 9.9% in the NRT arm and 18.0% in the e-cigarette arm (risk ratio 1.83, 95% confidence interval 1.30 to 2.58; p < 0.001). The e-cigarette arm had significantly higher validated quit rates at all time points. Participants in the e-cigarette arm showed significantly better adherence and experienced fewer urges to smoke throughout the initial 4 weeks of their quit attempt than those in the NRT arm, and gave their allocated product more favourable ratings. They were also more likely to be still using their allocated product at 1 year (39.5% vs. 4.3%, χ 2 = 161.4; p < 0.001). Participants assigned to e-cigarettes reported significantly less coughing and phlegm at 1 year than those assigned to NRT (controlling for smoking status). A detailed economic analysis confirmed that, because e-cigarettes incur lower NHS costs than NRT and generate a higher quit rate, e-cigarette use is more cost-effective. Limitations: The results may not be generalisable to other types of smokers or settings, or to cartridge-based e-cigarettes. Conclusions: Within the context of multisession treatment for smokers seeking help, e-cigarettes were significantly more effective than NRT. If SSSs provide e-cigarette starter packs, it is likely to boost their success rates and improve their cost-efficacy. Future work: The efficacy of e-cigarettes provided with different levels of support will show whether smokers should be encouraged to switch to vaping within support services or whether e-cigarettes can be recommended with less intensive or no support. Trial registration: Current Controlled Trials ISRCTN60477608. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment ; Vol. 23, No. 43. See the NIHR Journals Library website for further project information. The trial was supported by the Cancer Research UK Prevention Trials Unit (grant A16893).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nine trials reported on the potential short-term harms of electronic cigarette use for cessation; none suggested relatively higher rates of serious AEs.[76](#R76)-[80](#R80),[82](#R82),[86](#R86),[87](#R87),[89](#R89)”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [86]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Five trials (N=3,117) were included that evaluated the effectiveness of using e-cigarettes to help current conventional smokers stop or reduce smoking compared with placebo or nicotine replacement therapy ([eTable 3](#SD1)).[76](#R76),[77](#R77),[86](#R86),[87](#R87),[89](#R89)”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990
Decision Modelling For Health Economic Evaluation
Briggs, A., Claxton, K., & Sculpher, M. (2006) · doi:10.1093/oso/9780198526629.001.0001 · Cited by 3,153
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · cited 2×
“Resource Trial arm, mean (SE) (£) NRT (n= 447) E-cigarette (n= 439) Mean cost in the 6 months before baseline Smoking cessation help cost 9 (1) 8 (1) Pharmacotherapy cost 24 (7) 20 (7) Health-care service use cost 612 (108) 512 (62) Cost to the NHS 645 (109) 539 (62) Mean cost in the 6 months post TQD Smoking cessatio…”
BackgroundInternational Agency for Research on Cancer (IARC)
(2018) · The Grants Register 2018 · doi:10.1007/978-1-349-94186-5_629 · Cited by 2,801
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464 · cited 3×
“Variable Missing values, n (%) Age 0 (0) Sex 0 (0) Trial site 0 (0) Entitlement to free prescriptions 0 (0) Ethnicity 0 (0) Intervention cost Training 0 (0) Delivery 0 (0) Baseline FTCD 0 (0) Smoking cessation help cost Baseline 0 (0) 6 months 307 (35) 12 months 285 (32) Pharmacotherapies prescription cost Baseline 0…”
Background
Research works printed but not linked: 7
- Public Health England, 2018, E-cigarettes and Heated Tobacco Products: Evidence Review
- West, 2018, Trends in electronic cigarette use in England. Smoking Toolkit Study
- Curtis, 2016, Unit Costs of Health and Social Care 2016
- NHS Business Services Authority, 2017, PD1 reports
- National Institute for Health and Care Excellence (NICE), 2017, Position Statement on Use of the EQ-5D-5L Valuation Set
- Office for National Statistics (ONS), 2017, Deaths registered in England and Wales: 2016
- Curtis, 2015, Unit Costs of Health and Social Care 2015
Cited by
Electronic cigarettes for smoking cessation
Hartmann-Boyce, J., Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub7 · Cited by 320
Self-citationElectronic cigarettes for smoking cessation
Hartmann-Boyce, J., McRobbie, H., Butler, A. R., Lindson, N., Bullen, C., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub5 · Cited by 312
Self-citationLe Foll, B., Piper, M. E., Fowler, C. D., Tonstad, S., Bierut, L., Lu, L., Jha, P., & Hall, W. D. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00346-w · Cited by 316
Electronic cigarettes for smoking cessation
Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Hajek, P., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., et al. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub8 · Cited by 170
Self-citationInterventions for Tobacco Cessation in Adults, Including Pregnant Persons
Patnode, C. D., Henderson, J. T., Coppola, E. L., Melnikow, J., Durbin, S., & Thomas, R. G. (2021) · JAMA · doi:10.1001/jama.2020.23541 · Cited by 212
Electronic cigarettes for smoking cessation
Hartmann-Boyce, J., McRobbie, H., Butler, A. R., Lindson, N., Bullen, C., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub6 · Cited by 168
Self-citationElectronic cigarettes for smoking cessation
Lindson, N., Butler, A. R., McRobbie, H. J., Bullen, C., Hájek, P., Wu, A. D., Begh, R. A., Theodoulou, A., Notley, C. J., Rigotti, N. A., et al. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub9 · Cited by 188
Self-citationE-Cigarettes—a review of the evidence—harm versus harm reduction
Feeney, S., Rossetti, V., & Terrien, J. (2022) · Tobacco Use Insights · doi:10.1177/1179173x221087524 · Cited by 129
“It is important to note, however, that 80% of e-cigarette users were still using them at 12 months vs 9% of NRT users.(28,29)Myers-Smith, et al, studied”
BackgroundElectronic cigarettes for smoking cessation.
(2012) · PubMed · Cited by 116
COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up
Polosa, R., Morjaria, J. B., Prosperini, U., Busà, B., Pennisi, A., Malerba, M., Maglia, M. G., & Caponnetto, P. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320961617 · Cited by 101
Glasser, A., Vojjala, M., Cantrell, J., Levy, D. T., Giovenco, D. P., Abrams, D. B., & NIAURA, R. S. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaa182 · Cited by 84
A review of tobacco abuse and its epidemiological consequences
Omare, M. O., Kibet, J. K., Cherutoi, J. K., & Kengara, F. O. (2021) · Journal of Public Health · doi:10.1007/s10389-020-01443-4 · Cited by 78
“BaP has been classified by IARC as a group 2A cancer causing chemical and is therefore a risk chemical (IARC 2019; Vu et al. 2015The introduction of electronic cigarettes was supposed to promise safer cigarettes suggested to deliver low nicotine levels (Carlsen and Skjerven 2018; Hajek et al. 2019).”
BackgroundLi, J., Hájek, P., Pesola, F., Wu, Q., Phillips‐Waller, A., Przulj, D., Smith, K. M., Bisal, N., Sasieni, P. D., Dawkins, L., et al. (2019) · Addiction · doi:10.1111/add.14829 · Cited by 55
“The project has been published in full in Health Technology Assessment [6].”
MethodSelf-citationElectronic cigarettes for smoking cessation
Lindson, N., Livingstone‐Banks, J., Butler, A. R., McRobbie, H. J., Bullen, C., Hájek, P., Wu, A. D., Begh, R. A., Theodoulou, A., Notley, C. J., et al. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub10 · Cited by 127
Self-citationEvidence, alarm, and the debate over e-cigarettes
Fairchild, A. L., Healton, C. G., Curran, J. W., Abrams, D. B., & Bayer, R. (2019) · Science · doi:10.1126/science.aba0032 · Cited by 44
Use of Vaping as a Smoking Cessation Aid: A Review of Clinical Trials
Ashour, A. M. (2023) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s419945 · Cited by 43
“54 Nevertheless, evidence of the long-term efficacy of e-cigarettes for smoking cessation is still limited.”
BackgroundAqeeli, A. A., Makeen, A. M., Bahhawi, T. A., Ryani, M. A., Bahri, A. A., Alqassim, A. Y., & El‐Setouhy, M. (2020) · Health & Social Care in the Community · doi:10.1111/hsc.13184 · Cited by 43
Giovanazzi, A., Jones, K., Carr, R. M., Fairhurst, C. M., Backhouse, M. R., & Adamson, J. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106788 · Cited by 35
Gravely, S. M. L., Meng, G., Hammond, D. G., Hyland, A. J., Cummings, K. M., Borland, R., Kasza, K. A., Yong, H., Thompson, M. E., Quah, A. C. K., et al. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107339 · Cited by 28
Efficacy of Electronic Cigarettes for Smoking Cessation: A Systematic Review and Meta-Analysis
Ibrahim, S., Habiballah, M., & Sayed, I. E. (2020) · American Journal of Health Promotion · doi:10.1177/0890117120980289 · Cited by 25
“As mentioned previously, NRT combinations are more effective than a single NRT.”
BackgroundMethodInfluentialQuigley, J. M., Walsh, C., Lee, C., Long, J., Kennelly, H., McCarthy, A., & Kavanagh, P. M. (2021) · Tobacco Prevention & Cessation · doi:10.18332/tpc/143077 · Cited by 23
Simms, L., Rudd, K., Palmer, J. A., Czekala, L., Yu, F., Chapman, F., Sticken, E. T., Wieczorek, R., Bode, L. M., Stevenson, M., et al. (2020) · Current Research in Toxicology · doi:10.1016/j.crtox.2020.11.001 · Cited by 21
Bowker, K., Ussher, M., Cooper, S., Orton, S., Coleman, T., & Campbell, K. A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17134823 · Cited by 16
“Outside of pregnancy, a large randomised control trial has shown that in non-pregnant smokers, e-cigarettes were more effective than nicotine replacement therapy (NRT) for quitting smoking [20].”
BackgroundHuman abuse liability assessment of e‐cigarettes: Why, what and how?
Fearon, I. M. (2022) · Drug Testing and Analysis · doi:10.1002/dta.3251 · Cited by 15
Luo, J., Bian, L.-H., Yao, Z., Wang, X., Li, Q., Guo, J., & Shi, J. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136152 · Cited by 15
Nicotine as a female reproductive toxicant—A review
Bhardwaj, J. K., Siwach, A., & Sachdeva, S. N. (2024) · Journal of Applied Toxicology · doi:10.1002/jat.4702 · Cited by 15
Lohner, V., McNeill, A. D., Schneider, S. O., Vollstädt‐Klein, S., Andreas, M., Szafran, D., Grundinger, N., Demjén, T., Fernández, E., Przewoźniak, K., et al. (2023) · Addiction · doi:10.1111/add.16162 · Cited by 15
Ahuja, N. A., Kedia, S., Jiang, Y., Xie, L., Ward, K. D., Pichon, L. C., Dillon, P., & Yu, X. (2022) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2022.07.001 · Cited by 13
Bizoń, M., Maciejewski, D., & Kolonko, J. (2020) · Anaesthesiology Intensive Therapy · doi:10.5114/ait.2020.97989 · Cited by 14
“Some devices are also equipped with a red diode, lighting up on each aerosol aspiration and imitating cigarette glow [7, 9, 15].”
BackgroundNehme, A. M. A., Lou, X., Yan, X., Lee, J., & Salloum, R. G. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107284 · Cited by 12
Buss, V. H., Beard, E., Shahab, L., Simonavičius, E., Bauld, L., Brown, J., & Brose, L. S. (2026) · Addiction · doi:10.1111/add.70332 · Cited by 12
“…Smoking Service sites, which offered participants either vapes or nicotine replacement therapy along with behavioural support, showed that vapes were significantly more effective than nicotine replacement therapy and providing vape starter kits had the potential to increase quit success rates [26].”
Electronic cigarettes for smoking cessation
Lindson, N., Livingstone‐Banks, J., Butler, A. R., McRobbie, H., Bullen, C., Hájek, P., Wu, A. D., Begh, R. A., Theodoulou, A., Ma, C., et al. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub11 · Cited by 11
Self-citationE-Cigarettes and the Comparative Politics of Harm Reduction: History, Evidence, and Policy
Berridge, V. S., Bayer, R., Fairchild, A. L., & Hall, W. (2023) · Springer eBooks · doi:10.1007/978-3-031-23658-7 · Cited by 11
E-cigarettes: What evidence links vaping to acute lung injury and respiratory failure?
Párraga, G., & Morissette, M. C. (2019) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2019.1684857 · Cited by 8
“Unfortunately, controlled studies that measure smoking cessation rates in ecigarette users are limited and have limitations.(40,41) In a recent trial,(41) which was editorialized(42) and critiqued,(43,45) there was an improved rate of smoking cessation in randomized e-cigarette users as compared to nicotine replacemen…”
BackgroundGaliatsatos, P., Garfield, J. L., Melzer, A. C., Leone, F. T., Farber, H. J., Ruminjo, J. K., & Thomson, C. C. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202008-971cme · Cited by 9
Dawkins, L., Soar, K., Pesola, F., Ford, A., Notley, C. J., BROWN, R. M. A., Ward, E., McMillan, L., Robson, D., Varley, A., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04167-y · Cited by 8
“…of EC ( n = 13: nervous, headache, sweaty, weak, nausea, pounding heart, throat/mouth irritation, sleep disturbance, dizziness, shortness of breath, cough, wheezy, and phlegm production) based on previous studies [13, 21, 22] were each rated on a 5-point scale from 1 (not at all) to 5 (extremely).”
Self-citationEvidence against e-cigarettes for smoking cessation
Teriba, A., Mbama, U., Sharma, S., Abraham, A., & Ndefo, U. A. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.05.001 · Cited by 7
Frosina, J., McEwan, M., Ebajemito, J. K., Thissen, J., Taluskie, K., Baxter-Wright, S., & Hardie, G. (2023) · Scientific Reports · doi:10.1038/s41598-023-37539-6 · Cited by 7
Correlates of e-cigarette use among adults initiating smoking cessation treatment
Boozary, L. K., Frank-Pearce, S. G., Alexander, A. C., Waring, J. J. C., Ehlke, S. J., Businelle, M. S., Cohn, A. M., & Kendzor, D. E. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108724 · Cited by 7
Electronic Cigarette Use and the Diagnosis of Nonmelanoma Skin Cancer Among United States Adults
Dugan, K., Breit, S., Okut, H., & Ablah, E. A. (2021) · Cureus · doi:10.7759/cureus.19053 · Cited by 6
Public perceptions of the FDA’s marketing authorization of Vuse on Twitter/X
Lee, S., Xie, Z., Xu, E., Shao, Y., Ossip, D. J., & Li, D. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1280658 · Cited by 6
Belderson, P., Ward, E., Pope, I., & Notley, C. J. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078677 · Cited by 6
Taylor, E. V., Aleyan, S., East, K. A., Cummings, K. M., Thrasher, J. F., Fong, G. T., Quah, A. C. K., Li, G., Borland, R., Hammond, D. G., et al. (2021) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntab256 · Cited by 6
Squires, H., Gillespie, D., Kock, L. S., Everson-Hock, E., Hiscock, R., Bogdanovica, I., Lewis, C., Robson, D., Filippidis, F. T., Langley, T. E., et al. (2025) · NIHR Open Research · doi:10.3310/nihropenres.14038.1 · Cited by 6
“…from one UK study 54 and two England focussed studies 45,55 that vapes are used by adults attempting to quit smoking and are associated with higher success rates compared to attempts without vapes or sometimes compared to NRT use, especially in supported settings or with daily use 3,64,65 .”
Pesola, F., Phillips‐Waller, A., Przulj, D., Smith, K. M., & Hájek, P. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1064 · Cited by 5
Self-citationHallingberg, B., Angel, L., BROWN, R. M. A., Copeland, L., Gray, L., Godwin, J. V., & Moore, G. F. (2021) · BMC Public Health · doi:10.1186/s12889-021-12004-z · Cited by 5
A Clinical Review on Chronic Obstructive Pulmonary Disease
Suriyakumar, S., Sivadasan, S., Srinivass, T. V., & Aiyalu, R. (2024) · Future Integrative Medicine · doi:10.14218/fim.2023.00026 · Cited by 4
Ashok, S., Ramdurg, S. I., & Chaukimath, S. (2024) · Cureus · doi:10.7759/cureus.68403 · Cited by 4
“A study in 2019 found that e-cigarettes were found to be almost twice as effective as nicotine-replacement therapy in helping participants quit smoking [15].”
BackgroundFearon, I. M., Seltzer, R. G. N., Houser, T. L., Tope, A., Cahours, X., Verron, T., Malt, L., Nahde, T., O'Connell, G., & Nides, M. A. (2022) · Drug Testing and Analysis · doi:10.1002/dta.3335 · Cited by 4
Use of tobacco cessation aids and likelihood of smoking cessation: A French population-based study
Fekom, M., Aarbaoui, T. E., Guignard, R., Andler, R., Quatremère, G., Ducarroz, S., Nguyen‐Thanh, V., & Melchior, M. (2022) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2022.102044 · Cited by 4
“Second, as reported by an extensive randomized controlled trial comparing these two smoking cessation aids, compliance with NRT prescription is not always guaranteed among individuals who were dispensed NRT products (Hajek et al., 2019).”
BackgroundInfluentialFearon, I. M., Seltzer, R. G. N., Houser, T. L., Tope, A., Cahours, X., Verron, T., Malt, L., Nahde, T., O'Connell, G., & Nides, M. A. (2023) · Drug Testing and Analysis · doi:10.1002/dta.3450 · Cited by 3
Jackson, A. B., Gibbons, F. X., Fleischli, M. E., Haeny, A. M., Bold, K. W., Suttiratana, S. C., Fagan, P., Krishnan‐Sarin, S., & Gerrard, M. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.208985 · Cited by 2
Sifat, M. S., Alexander, A. C., Businelle, M. S., Frank-Pearce, S. G., Boozary, L. K., Wagener, T. L., Ahluwalia, J. S., & Kendzor, D. E. (2024) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2024.100295 · Cited by 2
Luy, M. T., Airagnes, G., Matta, J., Toubiana, L., Allagbé, I., Limosin, F., & Faou, A.-L. L. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1967987 · Cited by 2
“…nicotine, and NRT), abstinence was similar in all groups (Bullen et al., 2013), whereas in another trial with two arms (e-cigarettes with nicotine versus NRT) and an open design, the quit rate was significantly higher in the e-cigarette with nicotine arm than in the NRT arm (Hajek et al., 2019).”
Nutrition status and obesity paradox in chronic obstructive pulmonary disease
Drapkina, O. M., Avdeev, S. N., Budnevsky, A. V., Ovsyannikov, Е. S., Васильевна, К. А., & Дробышева, Е. С. (2021) · Voprosy Pitaniya · doi:10.33029/0042-8833-2021-90-6-42-49 · Cited by 2
Zahrani, Y. I., & Ghamdi, I. A. (2024) · King Khalid University journal of health sciences. · doi:10.4103/kkujhs.kkujhs_25_24 · Cited by 1
Nabi, M. H., Chowdhury, A. T., & Hossian, M. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07427-5 · Cited by 1
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-7071-5 · Cited by 1
Siwach, A., & Bhardwaj, J. K. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70758 · Cited by 1
“Tobacco consumption occurs through smoked and smokeless tobacco products, which include tobacco paste, naswar, snus, loosely chewed tobacco leaves, electronic cigarettes, bidis, cigarettes, and water pipes [ 2, 3].”
E-Cigarettes and the Burdens of History: Children, Bystanders and the American War on Nicotine
Bayer, R., & Fairchild, A. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-23658-7_4 · Cited by 1
Quigley, J. M., Walsh, C., Lee, C., Long, J., Kennelly, H., McCarthy, A., & Kavanagh, P. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3739810 · Cited by 1
Jeffares, Y. (2020) · Massey Research Online (Massey University)
Abbas, S., Abbas, B., Khan, F. N., Ehsan, H. R. U., Malik, A., & Malik, S. M. (2022) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v72isuppl-2.4028
Pharmacological approach to smoking cessation and effective intervention models
Alzahrani, H. H., Alasmari, Y. M., Almutairi, N. A., Aldajani, S. G., Alanazi, F. O., Alsadiq, A. A., Alanazi, E. J., Moailo, H. A. A., Alotaibi, J. T. A., Alsubhi, A. M., et al. (2022) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20223567
Law, V., Afolalu, E. F., Abetz‐Webb, L., Wemyss, L. A., Turner, A., & Chrea, C. (2025) · JMIR Formative Research · doi:10.2196/58614
Couto, L., Hust, S. J. T., Nickerson, C. G., & Robinson-Tay, K. (2025) · Journal of Interpersonal Violence · doi:10.1177/08862605251355974
“Efficacy has been associated with smoking cessation (Hajek et al., 2019), exercising (Huang & Ren, 2020; Reigal et al., 2020), and bystander intervention behavior, specifically among first-year college students (Evans et al., 2019).”
Vaping likely has dangers that could take years for scientists to even know about
Jaspers, I. (2019) · The Conversation · doi:10.64628/aai.fmeyeqkjn
Jaspers, I. (2019) · The Conversation · doi:10.64628/aap.xnffy3hyu
Some smokers credit e-cigarettes with saving their lives – does that matter?
Kurti, A. N. (2019) · The Conversation · doi:10.64628/aai.93terqc5c
Hallingberg, B., Angel, L., Brown, R., Copeland, L., Gray, L., Godwin, J. V., & Moore, G. (2021) · Figshare · doi:10.6084/m9.figshare.16863732
Moore, E., Gillespie, D., Simonavičius, E., & Brose, L. S. (2026) · Addiction · doi:10.1111/add.70462
“[25].”
Soar, K., Ford, A., Brown, R., Pesola, F., Robson, D., Notley, C. J., McMillan, L., Ward, E., Tyler, A., Varley, A., et al. (2025) · Public Health Research · doi:10.3310/gjld1918
Self-citationVerron, T., Guo, M., Clarke, L., Nahde, T., & Cahours, X. (2026) · Research Square · doi:10.21203/rs.3.rs-10279711/v1
Li, C., Zhang, M., Zhao, J., Zhao, A., Ye, J., Zhao, Y., & Hou, X. (2026) · Tobacco Induced Diseases · doi:10.18332/tid/235831
“In 2003, Chinese engineers invented the e-cigarette; since 2007, these devices have become increasingly prevalent in high-income countries, often marketed as smoking cessation aids in some nations 2,3 .”
Metadata
- Authors
- Hajek, P., Phillips-Waller, A., Przulj, D., Pesola, F., Smith, K. M., Bisal, N., Li, J., Parrott, S., Sasieni, P., Dawkins, L., Ross, L., Goniewicz, M., Wu, Q., & McRobbie, H. J.
- Affiliations
- Health and Lifestyle Research Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK
- Queen Mary University of London (GB)
- King's College London (GB)
- University of York (GB)
- London South Bank University (GB)
- Leicester City Council (GB)
- Roswell Park Comprehensive Cancer Center (US)
- ORCID
- Venue
- Health Technology Assessment
- Published
- 2019-08
- Volume
- 23
- Issue
- 43
- Pages
- 1-82
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- PMC
- PMC6732716
- OpenAlex
- W2969327526
- Cited by
- 72
- References
- 67
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 8 · 2023: 8 · 2022: 13 · 2021: 14 · 2020: 9 · 2019: 6
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- Research Open (London South Bank University) (acceptedVersion, cc-by-nc)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Portal (King's College London) (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Funders
- Health Technology Assessment programme (12/167/135)
- Cancer Research UK Prevention Trials Unit (A16893)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- nicotine replacement therapy, smoking cessation, smoking cessation services, sustained abstinence, behavioral support, cost-efficacy, medication adherence, adverse effects, respiratory health, e-liquids
- MeSH terms
- Adult, Behavior Therapy, Cost-Benefit Analysis, Female, United Kingdom, Humans, Male, Smoking Cessation, Tobacco Use Cessation Devices, Electronic Nicotine Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.